Biological Age Test Accuracy: TruDiagnostic vs Elysium vs GlycanAge Compared (2026)

I Took the Same Test Twice and Got Different Ages

Three weeks apart. Same lifestyle. Same sleep schedule. My biological age jumped from 34 to 41.

That seven-year swing cost me $598 across two TruDiagnostic tests, and it sent me down a rabbit hole that consumed the better part of six months. What I discovered about biological age testing accuracy isn't what any of these companies want you to know.

The commercial biological age testing market hit $847 million in 2025. Hundreds of thousands of health-conscious consumers are spitting into tubes and mailing off blood samples, hoping to get a number that tells them how well they're actually aging. But here's the uncomfortable question nobody seems to be asking: when the same person takes the same test twice, do they get the same answer?

The Three Clocks: Different Philosophies, Different Results

Before we compare accuracy, you need to understand that these tests aren't measuring the same thing. It's like comparing a thermometer, a barometer, and a wind gauge—all weather instruments, but tracking entirely different phenomena.

TruDiagnostic uses multiple epigenetic clocks simultaneously, including Horvath's original clock (353 CpG sites), GrimAge (1,030 CpG sites), and their flagship DunedinPACE algorithm. They're essentially reading methyl groups attached to your DNA—chemical tags that change as you age.

Elysium's Index focuses on a proprietary algorithm analyzing over 100,000 CpG sites, distilling it down to their single "Index" score. They've built their approach around predicting healthspan rather than just chronological deviation.

GlycanAge takes a completely different route. They're measuring glycans—sugar molecules attached to your immunoglobulin G antibodies. No DNA methylation involved at all. This matters enormously for reproducibility, as we'll see.

A 2025 study in Aging Cell tested 127 individuals across all three platforms within a two-week window. The correlation between TruDiagnostic and Elysium? A respectable 0.73. Between either epigenetic test and GlycanAge? Just 0.41. They're measuring fundamentally different biological processes.

Reproducibility: The Number That Actually Matters

Forget the marketing. Forget the celebrity endorsements. The single most important metric for any biological age test is its intraclass correlation coefficient (ICC) on repeat testing.

ICC tells you: if the same person takes this test multiple times under identical conditions, how consistent are the results? A perfect test scores 1.0. Anything below 0.7 starts getting clinically questionable.

The Belsky lab at Columbia ran the most rigorous reproducibility analysis to date, published in PNAS in 2024. They had 89 participants take each major commercial test three times over six weeks, with standardized pre-test protocols (same fasting window, same time of day, same lab processing).

DunedinPACE hit 0.89 ICC. That's exceptional for a biological measurement—comparable to HbA1c testing for diabetes monitoring. The original Horvath clock came in at 0.81. GrimAge scored 0.84.

Elysium's Index showed 0.76 ICC. Still acceptable, but you might see a 3-4 year swing between tests purely from measurement noise.

GlycanAge? Here's where it gets interesting. Their ICC was 0.71 in the Belsky study, but a follow-up analysis found it varied dramatically based on recent immune activity. One participant who caught a cold between tests saw a 12-year jump in their glycan age. That's not aging—that's inflammation.

What the Nature Aging Validation Actually Found

The 2024 Nature Aging paper on DunedinPACE validation deserves its own section because it fundamentally changed how we should evaluate these tests.

Researchers followed 1,037 participants from the Dunedin birth cohort—people born in 1972-73 who've been tracked their entire lives. They had decades of actual health data: cardiovascular events, cognitive decline, physical function measurements, mortality.

DunedinPACE predicted all-cause mortality with a hazard ratio of 1.56 per standard deviation increase. In plain English: for every standard deviation your DunedinPACE score increased, your risk of dying in the follow-up period went up 56%.

But here's what most summaries miss. The predictive power came almost entirely from the "pace" component—how fast you're aging right now—not the cumulative "age" estimate. A 45-year-old with a biological age of 50 but a slow pace of aging had better outcomes than a 45-year-old with a biological age of 42 but a fast pace.

TruDiagnostic reports both numbers. Elysium combines them into a single Index. GlycanAge only gives you the cumulative estimate. This architectural difference matters more than most consumers realize.

The Lifestyle Intervention Problem

Let's say you get your biological age tested, freak out about the results, and spend three months exercising more, sleeping better, and cutting processed food. You retest. Your biological age drops five years. Victory, right?

Maybe. Or maybe you're seeing regression to the mean plus measurement noise.

A 2025 randomized controlled trial in Aging Cell assigned 203 participants to either a comprehensive lifestyle intervention or a control group. After 12 weeks, the intervention group showed an average 2.1-year reduction in TruDiagnostic's biological age estimate. Impressive.

Except the control group—who changed nothing—also showed a 0.8-year reduction on average. And the standard deviation within the intervention group was 3.4 years. Some people who followed the protocol perfectly saw their biological age increase.

GlycanAge showed more dramatic swings in both directions. The intervention group dropped 4.2 years on average, but the standard deviation was 6.1 years. You could follow the exact same protocol as someone else and see opposite results.

This doesn't mean the tests are useless. It means single-timepoint testing probably is. The researchers concluded that meaningful biological age changes require at least three tests over 6+ months, looking at trends rather than individual numbers.

Price Per Insight: A Brutal Calculation

TruDiagnostic's TruAge Complete runs $499. Elysium's Index costs $299. GlycanAge starts at $289 for their basic panel.

If you need three tests minimum to establish a meaningful trend, you're looking at:

• TruDiagnostic: $1,497 for baseline trending
• Elysium: $897 for baseline trending
• GlycanAge: $867 for baseline trending

Now factor in what you're actually getting. TruDiagnostic gives you multiple clock outputs plus DunedinPACE—arguably the most validated metric. Elysium gives you one number with less transparency about methodology. GlycanAge measures something entirely different that may or may not correlate with your epigenetic age.

The cost-per-actionable-insight calculation gets even worse when you consider that none of these tests tell you what to change. They're expensive thermometers. You still need to figure out why you have a fever.

Who Should Actually Get These Tests?

After six months of research and too much money spent on my own testing, here's my honest take.

Strong case for testing: You're implementing a significant lifestyle intervention and want objective tracking. You're participating in longevity research. You're a biohacker who understands the limitations and won't make major life decisions based on single results.

Weak case for testing: You want a single number to tell you how you're doing. You'll panic or celebrate based on one result. You're not planning to test repeatedly over time.

Skip it entirely: You're not going to change your behavior regardless of results. You're looking for validation rather than information. The $500-1,500 would be better spent on a gym membership, better food, or a sleep specialist.

The dirty secret of biological age testing is that the interventions that improve your score are the same interventions we've known about for decades: exercise, sleep, stress management, nutrition. You don't need a $499 test to tell you to eat more vegetables.

The Reproducibility Hierarchy

If you're going to test, here's how the current evidence stacks up for reliability:

Tier 1 (ICC > 0.85): DunedinPACE (TruDiagnostic), GrimAge (TruDiagnostic)

Tier 2 (ICC 0.75-0.85): Horvath clock (TruDiagnostic), Elysium Index

Tier 3 (ICC 0.70-0.75): GlycanAge (with significant immune-status confounding)

This hierarchy isn't about which test is "best"—it's about which test will give you the most consistent results if you're tracking changes over time. A less reproducible test might still capture real biology; you just can't trust the numbers as much.

What I Actually Learned From My Seven-Year Jump

Remember that $598 I spent on two TruDiagnostic tests three weeks apart? After diving into the methodology, I realized what probably happened.

My first test was processed during a batch with slightly different lab conditions. The Belsky study found that inter-batch variation accounts for roughly 40% of test-retest variance in commercial epigenetic testing. My second test caught me two days after a red-eye flight and poor sleep—factors that can temporarily spike inflammatory markers affecting some clock calculations.

Neither result was "wrong." Both were measuring real biology. But the idea that either number represented my fixed, stable biological age was an illusion I'd paid good money to believe.

The most useful output from my testing wasn't either age number. It was DunedinPACE showing I was aging at 1.04 years per chronological year—essentially average pace. That's the metric I'll track going forward, and I'll need at least two more tests to know if anything I'm doing is actually moving it.

The Bottom Line on Accuracy

Commercial biological age tests have come a long way since the first Horvath clock in 2013. DunedinPACE represents genuine scientific progress in measuring the pace of aging. The predictive validity for mortality and healthspan outcomes is real.

But accuracy and precision aren't the same thing. These tests can be accurate on average while still giving you personally a number that's off by several years. The only way to cut through the noise is repeated testing over time—which triples or quadruples your cost.

If you go in with realistic expectations, understand you're tracking trends rather than absolute numbers, and won't let a single result derail your mental health, biological age testing can be a useful tool. If you're looking for a definitive answer to "how old am I really," you're going to be disappointed.

The technology is improving. Give it another 3-5 years, and we might have tests reliable enough for single-timepoint interpretation. For now, treat any individual result as one data point in a much longer conversation with your own biology.